Posted by Michael Wonder on 26 Jun 2022
US seeks pharmaceutical deal with Switzerland to fast-track FDA approvals
27 June 2022 - The Biden administration wants to reach a narrow sectoral trade agreement with the Swiss pharmaceutical industry, the U.S. Ambassador to Switzerland told Blick am Sonntag.
The goal of the potential accord is to make it easier for the U.S. FDA to approve Swiss pharmaceuticals, Scott Miller said in an interview with the newspaper published Sunday.
